Clinical Trial Update: Multimodal Neuroimaging Genetic Biomarkers of Nicotine AddictionSeverity

View source ↗

Summary

This completed clinical trial investigates multimodal neuroimaging and genetic biomarkers to assess nicotine addiction severity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Nicotine Dependence | Status: COMPLETED